Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study

Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study

The present study aimed to evaluate the vaccine effectiveness (VE) of different doses of an inactivated coronavirus disease 2019 (COVID-19) vaccine against Omicron BA.2.2 infection in Beijing, China, 2022. Based on data from a previous cohabitation retrospective cohort of COVID-19 outbreak in Beijin...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuaibing Dong, Ying Sun, Zhaomin Feng, Yi Tian, Lei Jia, Xiaoli Wang, Quanyi Wang, Daitao Zhang, Peng Yang
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Viruses
Subjects:
Omicron BA.2.2
inactivated COVID-19 vaccines
vaccine effectiveness
COVID-19 pandemic
booster immunization
China
Online Access:https://www.mdpi.com/1999-4915/17/1/31
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1999-4915/17/1/31

Similar Items